Recommendations for Post-Operative RadioTherapy After Complete Resection of Thymoma—a French DELPHI Consensus Initiative

IF 21 1区 医学 Q1 ONCOLOGY
Clémence Basse MD , Jonathan Khalifa MD , François Thillays MD , Cécile Le Pechoux MD , Jean-Michel Maury MD, PhD , Pierre-Emmanuel Bonte PhD , Alexandre Coutte MD , Nicolas Pourel MD , Vincent Bourbonne MD , Olivier Pradier MD , Aurélie Belliere MD , Florence Le Tinier MD , Mélanie Deberne MD , Ronan Tanguy MD , Fabrice Denis MD , Laetitia Padovani MD , Audrey Zaccariotto MD , Thierry Molina MD, PhD , Lara Chalabreysse MD, PhD , Geoffrey Brioude MD, PhD , Angela Botticella MD
{"title":"Recommendations for Post-Operative RadioTherapy After Complete Resection of Thymoma—a French DELPHI Consensus Initiative","authors":"Clémence Basse MD ,&nbsp;Jonathan Khalifa MD ,&nbsp;François Thillays MD ,&nbsp;Cécile Le Pechoux MD ,&nbsp;Jean-Michel Maury MD, PhD ,&nbsp;Pierre-Emmanuel Bonte PhD ,&nbsp;Alexandre Coutte MD ,&nbsp;Nicolas Pourel MD ,&nbsp;Vincent Bourbonne MD ,&nbsp;Olivier Pradier MD ,&nbsp;Aurélie Belliere MD ,&nbsp;Florence Le Tinier MD ,&nbsp;Mélanie Deberne MD ,&nbsp;Ronan Tanguy MD ,&nbsp;Fabrice Denis MD ,&nbsp;Laetitia Padovani MD ,&nbsp;Audrey Zaccariotto MD ,&nbsp;Thierry Molina MD, PhD ,&nbsp;Lara Chalabreysse MD, PhD ,&nbsp;Geoffrey Brioude MD, PhD ,&nbsp;Angela Botticella MD","doi":"10.1016/j.jtho.2024.04.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Thymomas are rare intrathoracic malignancies that can relapse after surgery. Whether or not Post-Operative RadioTherapy (PORT) should be delivered after surgery remains a major issue. RADIORYTHMIC is an ongoing, multicenter, randomized phase 3 trial addressing this question in patients with completely R0 resected Masaoka-Koga stage IIb/III thymoma. Experts in the field met to develop recommendations for PORT.</p></div><div><h3>Methods</h3><p>A scientific committee from the RYTHMIC network identified key issues regarding the modalities of PORT in completely resected thymoma. A DELPHI method was used to question 24 national experts, with 115 questions regarding the following: (1) imaging techniques, (2) clinical target volume (CTV) and margins, (3) dose constraints to organs at risk, (4) dose and fractionation, and (5) follow-up and records. Consensus was defined when opinions reached more than or equal to 80% agreement.</p></div><div><h3>Results</h3><p>We established the following recommendations: preoperative contrast-enhanced computed tomography (CT) scan is recommended (94% agreement); optimization of radiation delivery includes either a four-dimensional CT-based planning (82% agreement), a breath-holding inspiration breath-hold–based planning, or daily control CT imaging (81% agreement); imaging fusion based on cardiovascular structures of preoperative and planning CT scan is recommended (82% agreement); right coronary and left anterior descending coronary arteries should be delineated as cardiac substructures (88% agreement); rotational RCMI/volumetric modulated arc therapy is recommended (88% agreement); total dose is 50 Gy (81% agreement) with 1.8 to 2 Gy per fraction (94% agreement); cardiac evaluation and follow-up for patients with history of cardiovascular disease are recommended (88% agreement) with electrocardiogram and evaluation of left ventricular ejection fraction at 5 years and 10 years.</p></div><div><h3>Conclusion</h3><p>This is the first consensus for PORT in thymoma. Implementation will help to harmonize practices.</p></div>","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":null,"pages":null},"PeriodicalIF":21.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Thoracic Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1556086424001618","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Thymomas are rare intrathoracic malignancies that can relapse after surgery. Whether or not Post-Operative RadioTherapy (PORT) should be delivered after surgery remains a major issue. RADIORYTHMIC is an ongoing, multicenter, randomized phase 3 trial addressing this question in patients with completely R0 resected Masaoka-Koga stage IIb/III thymoma. Experts in the field met to develop recommendations for PORT.

Methods

A scientific committee from the RYTHMIC network identified key issues regarding the modalities of PORT in completely resected thymoma. A DELPHI method was used to question 24 national experts, with 115 questions regarding the following: (1) imaging techniques, (2) clinical target volume (CTV) and margins, (3) dose constraints to organs at risk, (4) dose and fractionation, and (5) follow-up and records. Consensus was defined when opinions reached more than or equal to 80% agreement.

Results

We established the following recommendations: preoperative contrast-enhanced computed tomography (CT) scan is recommended (94% agreement); optimization of radiation delivery includes either a four-dimensional CT-based planning (82% agreement), a breath-holding inspiration breath-hold–based planning, or daily control CT imaging (81% agreement); imaging fusion based on cardiovascular structures of preoperative and planning CT scan is recommended (82% agreement); right coronary and left anterior descending coronary arteries should be delineated as cardiac substructures (88% agreement); rotational RCMI/volumetric modulated arc therapy is recommended (88% agreement); total dose is 50 Gy (81% agreement) with 1.8 to 2 Gy per fraction (94% agreement); cardiac evaluation and follow-up for patients with history of cardiovascular disease are recommended (88% agreement) with electrocardiogram and evaluation of left ventricular ejection fraction at 5 years and 10 years.

Conclusion

This is the first consensus for PORT in thymoma. Implementation will help to harmonize practices.

Abstract Image

Abstract Image

胸腺瘤完全切除术后放疗建议--法国 DELPHI 共识倡议。
背景:胸腺瘤是罕见的胸腔内恶性肿瘤,术后可能复发。术后是否应进行术后放疗(PORT)仍是一个重要问题。RADIORYTHMIC是一项正在进行的多中心随机三期试验,针对的是完全R0切除的Masaoka-Koga IIb/III期胸腺瘤患者。该领域的专家召开会议,为PORT.Methods.提出建议:RYTHMIC网络的科学委员会确定了完全切除胸腺瘤的PORT方式的关键问题。采用 DELPHI 方法对 24 位国内专家进行了提问,涉及 115 个问题:1/ 影像技术;2/ 临床靶体积(CTV)和边缘;3/ 对危险器官的剂量限制;4/ 剂量和分次;5/ 随访和记录。当意见达成一致的比例≥80%时,即为达成共识:我们提出了以下建议:推荐术前造影剂增强 CT 扫描(94% 的一致意见);优化放射剂量包括基于 4D-CT 的计划(82% 的一致意见)、基于屏气吸气的计划或每日控制 CT 图像(81% 的一致意见);建议根据术前和计划 CT 扫描的心血管结构进行成像融合(82% 一致);右冠状动脉和左前降支冠状动脉应作为心脏亚结构进行划定(88% 一致);建议采用旋转 RCMI/VMAT(88% 一致);总剂量为 50Gy(81% 一致),每分 1.8-2Gy(94% 一致);建议对有心血管疾病史的患者进行心脏评估和随访(88% 一致),并在 5 年和 10 年时进行心电图和 LVEF 评估:结论:这是首个关于胸腺瘤 PORT 的共识。结论:这是胸腺瘤 PORT 的首个共识,其实施将有助于统一实践。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Thoracic Oncology
Journal of Thoracic Oncology 医学-呼吸系统
CiteScore
36.00
自引率
3.90%
发文量
1406
审稿时长
13 days
期刊介绍: Journal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer,is the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies.The readship includes epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, radiologists, pathologists, nuclear medicine physicians, and research scientists with a special interest in thoracic oncology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信